Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET | Zendy

Alessandro Gozzetti | Zendy; Vania Rossi | Zendy; Alfonso Cerase | Zendy; Giulia Papini | Zendy; Marzia Defina | Zendy; Monica Bocchia | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

Author(s) -

Alessandro Gozzetti,

Vania Rossi,

Alfonso Cerase,

Giulia Papini,

Marzia Defina,

Monica Bocchia

Publication year - 2012

Publication title -

mediterranean journal of hematology and infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 31

ISSN - 2035-3006

DOI - 10.4084/mjhid.2012.041

Subject(s) - lenalidomide , medicine , multiple myeloma , magnetic resonance imaging , nuclear medicine , pomalidomide , pet ct , oncology , radiology , positron emission tomography

A 71 year old female with multiple myeloma presented with back pain seven year after autologous stem cell transplant. Skeletal bone survey and magnetic resonance imaging did not show a relapse that was evidenced by CT/PET. Lenalidomide as single agent induced a complete disappearance of the lesions 6 months later and confirmed after one year at CT/PET.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research